Heart Failure clinical trials
Showing 51–100 of 287 active trials. Describe your situation to see which ones look like a fit.
- Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
- Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
- Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
- The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)
- Splanchnic X: Splanchnic Nerve Block in Heart Failure With Reduced Ejection Fraction
- Fluid Guided Heart Failure Treatment at the Cleveland Clinic
- iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
- HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
- RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
- A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)
- His-Bundle Corrective Pacing in Heart Failure
- Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Effect of Music on Cardiopulmonary Exercise Capacity in Heart Failure Patients
- Ertugliflozin in Chronic Heart Failure
- Home-Based Cardiac Rehabilitation for Patients With Heart Failure
- Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study
- XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
- At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure
- A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- The ROle of Compression StocKings in Heart Failure Patients
- CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
- Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty
- Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
- Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome
- Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- COMPARE-VENT Feasibility Pilot Study
- Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
- Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
- Home Hospital for Suddenly Ill Adults
- Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial
- MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Left vs Left Randomized Clinical Trial
- Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
- IEEM-Heat and Heart Failure
- Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Failure in the Emergency Department
- Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
- Enhanced Nutritional Optimization in LVAD Trial
- Project 2: ACHIEVE- HF
- Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function
- Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
- Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
- Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
- Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)
- NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
- Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.